Stefano Monti

Active 1995–2026

106
Papers
27,432
Citations
49
h-index
82
i10-index

Citations

Citations per year for Stefano Monti1981: 1 citations1990: 1 citations1992: 1 citations1996: 3 citations1997: 1 citations1998: 3 citations1999: 3 citations2000: 7 citations2001: 6 citations2002: 40 citations2003: 70 citations2004: 112 citations2005: 135 citations2006: 145 citations2007: 159 citations2008: 218 citations2009: 315 citations2010: 379 citations2011: 448 citations2012: 507 citations2013: 486 citations2014: 501 citations2015: 491 citations2016: 453 citations2017: 444 citations2018: 430 citations2019: 1,030 citations2020: 1,021 citations2021: 1,056 citations2022: 802 citations2023: 574 citations2024: 766 citations2025: 360 citations2026: 28 citations1982–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1993–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,134 citing papers, 31.2% of this breakdownChina: 1,856 citing papers, 11.3% of this breakdownGermany: 919 citing papers, 5.6% of this breakdownUnited Kingdom: 891 citing papers, 5.4% of this breakdownItaly: 743 citing papers, 4.5% of this breakdownCanada: 694 citing papers, 4.2% of this breakdownFrance: 596 citing papers, 3.6% of this breakdownSpain: 472 citing papers, 2.9% of this breakdownJapan: 420 citing papers, 2.5% of this breakdownSwitzerland: 389 citing papers, 2.4% of this breakdownAustralia: 360 citing papers, 2.2% of this breakdownNetherlands: 332 citing papers, 2% of this breakdown
0%31.2%Other 22.2%

Fields

  • Biochemistry, Genetics and Molecular Biology42.3%
  • Medicine40.1%
  • Computer Science7.6%
  • Immunology and Microbiology3.9%
  • Neuroscience1.9%
  • Engineering0.7%
  • Other3.5%

Topics

  • Glioma Diagnosis and Treatment4.3%
  • Lymphoma Diagnosis and Treatment4%
  • Gene expression and cancer classification4%
  • Cancer Genomics and Diagnostics3.2%
  • Bioinformatics and Genomic Networks3.1%
  • Epigenetics and DNA Methylation1.9%
  • Other79.5%

Coauthors

All papers

Open in search
  1. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christie Kovar, Andrew Cree, Huyen Dinh, Jireh Santibanez, Vandita Joshi, Manuel L. Gonzalez‐Garay, Christopher A. Miller, Aleksandar Milosavljevic, David A. Wheeler, Richard A. Gibbs, L A Donehower, Kristian Cibulskis, Carrie Sougnez, Tim Fennell, Scott Mahan, Jane Wilkinson, Liuda Ziaugra, Robert C. Onofrio, Toby Bloom, Robert Nicol, Kristin Ardlie, Jennifer Baldwin, Stacey Gabriel, Eric S. Lander, Gad Getz, Wendy Winckler, Roel G.W. Verhaak, Michael S. Lawrence, Michael O’Kelly, Jim Robinson, Gabriele Alexe, Rameen Beroukhim, Scott L. Carter, Derek Y. Chiang, Josh Gould, Supriya Gupta, Josh Korn, Craig H. Mermel, Jill P. Mesirov, Stefano Monti, Huy Nguyen, Melissa Parkin, Michael Reich, Nicolas Stransky, Barbara A. Weir, Levi A. Garraway, Todd R. Golub, Matthew Meyerson, Jun Li, Robert S. Fulton, Michael D. McLellan, John Wallis, David E. Larson, Xiaoqi Shi, Rachel M. Abbott, Lucinda Fulton, Ken Chen, Daniel C. Koboldt, Michael C. Wendl, Rick Meyer, Yuzhu Tang, Ling Lin, John R. Osborne, Brian H. Dunford-Shore, Tracie L. Miner, Kim D. Delehaunty, Chris Markovic, G.M. Swift, William Courtney, Craig Pohl - Nature 2008 cited by 7,856

  2. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 cited by 1,972

  3. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data

    Authors: , , , - Machine Learning, Mach. Learn. 2003 cited by 2,181

  4. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

    Authors: , , , , , , , , , , , - Blood 2010 cited by 1,297

  5. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 2,586

  6. Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , - Cancer Cell 2012 cited by 528

  7. Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 766

  8. Targetable genetic features of primary testicular and primary central nervous system lymphomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret A. Shipp - Blood 2015 cited by 599

  9. Initial genome sequencing and analysis of multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robb Onofrio, Trevor J. Pugh, S. Vincent Rajkumar, Alex H. Ramos, David S. Siegel, Andrey Sivachenko, A. Keith Stewart, Suzanne Trudel, Ravi Vij, Douglas Voet, Wendy Winckler, Todd M. Zimmerman, John D. Carpten, J.M. Trent, William C. Hahn, Levi A. Garraway, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub - Nature 2011 cited by 1,455

  10. Multi-modal profiling of peripheral blood cells across the human lifespan reveals distinct immune cell signatures of aging and longevity

    Authors: , , , , , , , , , , - EBioMedicine 2023 cited by 85

  11. Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis

    Authors: , , , , , , , , , - Cell Reports 2021 cited by 69

  12. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

    Authors: - Blood 2004 cited by 823

  13. How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression

    Authors: , , , , , , , , , , - International Journal of Molecular Sciences 2020 cited by 108

  14. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndrome

    Authors: , , , , , , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 689

  15. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER−/PR−/Her2− Human Breast Cancer Cells

    Authors: , , , , , , , , , , , , , - Molecular Pharmacology 2016 cited by 160

  16. Yap suppresses T-cell function and infiltration in the tumor microenvironment

    Authors: , , , , , , - PLoS Biology 2020 cited by 110

  17. Protein signatures of centenarians and their offspring suggest centenarians age slower than other humans

    Authors: , , , , , , , , , , , , , - Aging Cell 2021 cited by 100

  18. Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells

    Authors: , , , , , , , , , , , , , , - Cell 2011 cited by 477

  19. Total RNA sequencing reveals gene expression and microbial alterations shared by oral pre-malignant lesions and cancer

    Authors: , , , , , , , , - Human Genomics 2023 cited by 30

  20. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells

    Authors: , , , , , , , , , - BMC Biology 2016 cited by 99

  21. Glutamine‐utilizing transaminases are a metabolic vulnerability of TAZ/YAP‐activated cancer cells

    Authors: , , , , , - EMBO Reports 2018 cited by 97

  22. Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition

    Authors: , , , , , , , , , , , , , - Molecular Cancer Research 2022 cited by 28

  23. SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas

    Authors: , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 174

  24. Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

    Authors: , , , , , , , , , , , , - Nature Communications 2022 cited by 39